INS and neoplasm: Subsequent multimodal imaging evaluation, including PET-CT, octreotide scintigraphy, and contrast-enhanced pancreatic MRI, effectively excluded insulinoma or other insulin-secreting neoplasms, ultimately confirming the diagnosis of IAS.